Relief’s 2024 Annual Report, which includes pipeline and portfolio updates, corporate governance and compensation disclosures, and financial statements, is available on the Company’s website.

Learn more about whether Moderna, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Given their life-saving potential, newborn screenings should not be seen as optional but as a fundamental part of postnatal ...

Learn more about whether Alvotech or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

As we focus on prioritizing preventive healthcare, genetic testing will remain the game-changer in reducing the burden of ...

Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria ... At the moment the main treatment strategy is to restrict phe in the ...

The Argentina inborn errors of protein metabolism (IEPM) market was valued at US$ 268.2 million in 2023 and is expected to achieve a market valuation of US$ 664.0 million by 2032. This impressive ...

Market OverviewThe global Newborn Screening Market is valued at USD 3.44 Billion in 2024 and is projected to reach a value of ...

It may lose some sweetness at high temperatures. People who have a condition called phenylketonuria should avoid this sweetener. Neotame (Newtame). It’s often used as a sugar substitute in baked ...

Metabolic diseases occur when the body's usual metabolic processes are disrupted. These diseases can be congenital or acquired, for example, diabetes and phenylketonuria.

Jaguar Health, Inc nnounced the results of a new survey of 27 board certified veterinary oncologists practicing in the U.S. regarding Canalevia-CA1 and the treatment of chemotherapy-induced ...